Literature DB >> 8109118

T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.

R L Thompson1, S Ranjbar, B J Rowlands.   

Abstract

Infective complications are a significant problem in the management of patients with obstructive jaundice, despite the widespread use of prophylactic antibiotics. The cause of this may be suppression of the immune system. This study investigates the effect of serum from an animal model of extrahepatic biliary obstruction (BDL) for 7, 14, and 21 days on the lymphoproliferative response of a single population of T-lymphocytes to the mitogen phytohemagglutinin (PHA). Mean stimulation counts for lymphocytes cultured with 7 days with BDL serum (938 +/- 90 p = 0.04) and for 21 days with BDL serum (844 +/- 253 p = 0.04) are significantly lower than control serum (2382 +/- 1340). The effect of 14 days BDL serum has some suppression of lymphocyte stimulation but this is not significant (1115 +/- 429 p = 0.06). There was no significant correlation with any clinical parameters including bilirubin and the duration of jaundice. We have concluded that serum from animals with obstructive jaundice is immunosuppressive, but further studies are required to identify the factor and its role in vivo.

Entities:  

Mesh:

Year:  1993        PMID: 8109118     DOI: 10.1007/bf01659096

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  12 in total

1.  Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins.

Authors:  J J Ellner; P J Spagnuolo
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.

Authors:  R L Thompson; M Hoper; T Diamond; B J Rowlands
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

3.  Impaired nonspecific cellular immunity in experimental cholestasis.

Authors:  P T Roughneen; D B Drath; A D Kulkarni; B J Rowlands
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

4.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

5.  Biliary obstruction and host defense failure.

Authors:  J M Holman; L F Rikkers
Journal:  J Surg Res       Date:  1982-03       Impact factor: 2.192

6.  Inhibitory effects of bilirubin and photobilirubin on neonatal and adult T lymphocytes and granulocytes.

Authors:  F F Rubaltelli; B Granati; A Fortunato; A Piovesan; G Casara; P Colleselli; G Semenzato
Journal:  Biol Neonate       Date:  1982

7.  Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage.

Authors:  P T Roughneen; D J Gouma; A D Kulkarni; W F Fanslow; B J Rowlands
Journal:  J Surg Res       Date:  1986-08       Impact factor: 2.192

8.  Impairment of human lymphocyte function by bile salts.

Authors:  R M Keane; T R Gadacz; A M Munster; W Birmingham; R A Winchurch
Journal:  Surgery       Date:  1984-04       Impact factor: 3.982

9.  Sepsis in the management of complicated biliary disorders.

Authors:  J M Holman; L F Rikkers; F G Moody
Journal:  Am J Surg       Date:  1979-12       Impact factor: 2.565

10.  Cell-mediated immunity in children with chronic cholestasis.

Authors:  G Maggiore; C De Giacomo; M S Scotta; S Siena; R Maccario; A Vitiello
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

View more
  2 in total

1.  Immunologic influences of hyperthermia in a rat model of obstructive jaundice.

Authors:  B M Güllüoğlu; A Bekraki; N Cerikçioğlu; G Söyletir; A O Aktan
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.